Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1301 of 5804
-
Can light and herbs boost ovarian function? new trial seeks answers
Disease control Recruiting nowDiminished Ovarian Reserve (DOR) refers to a reduction in the number of recruitable follicles in the ovaries and/or a decline in oocyte quality. Current research on its etiology and treatment remains unsatisfactory. This study will be conducted as a single-center, prospective, pa…
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New anesthesia combo may calm kids after surgery
Symptom relief Recruiting nowThe purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Tailored drug dosing may shield kids with sickle cell from organ damage
Disease control Recruiting nowThe main reason for this research study is to learn more about hydroxyurea and the treatment of sickle cell anemia (SCA). Hydroxyurea is a medication that has been studied for many years and has been shown to provide benefits for people with SCA. In this research study, the inve…
Phase: PHASE4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 26, 2026 17:45 UTC
-
New shot for eczema shows promise in Mid-Stage trial
Disease control OngoingAtopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. The purpose of this study is to evaluate the clinical efficacy and safety of single therapies and/or combination therapies for moderate to severe AD through multiple subs…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for rare kidney diseases: three drugs enter trial
Disease control Recruiting nowThis is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD). The purpose of this study is to measure the change in proteinuria and its impact on the rates of remission of nephrotic…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Weekly shot may shield joints in hemophilia a patients
Disease control OngoingThe rationale for conducting this open-label phase 4 study is to assess whether once-weekly prophylaxis with efanesoctocog alfa (50 IU/kg) improves the disease course of existing synovial hypertrophy and prevents the risk of joint bleeds in patients with moderate or severe haemop…
Phase: PHASE4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Chilling the inner ear: a cool new way to shield hearing?
Prevention Recruiting nowThe goal of this interventional clinical study is to investigate the use of mild therapeutic hypothermia devices for preservation of sensory structures in the cochlea after noise exposure. The main aims of the study are: 1. To test the safety and best duration for use for a new …
Phase: NA • Sponsor: Restorear Devices LLC • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
New drug BL-M11D1 takes aim at tough leukemia in early trial
Disease control Recruiting nowThe objective of this study to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of BL-M11D1 in patients with relapsed/refractory acute myeloid leukemia.
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug PT0253 targets Hard-to-Treat KRAS G12D cancers
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability, determine the maximally tolerated dose (MTD) and/or recommended Phase 2 dose(s) (RP2D) of PT0253 in adult participants with Kirsten rat sarcoma viral oncogene homolog (KRAS) G12D mutated advanced solid …
Phase: PHASE1 • Sponsor: PAQ Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could stem cell secretions help seniors regain muscle strength?
Disease control OngoingPlacebo controlled study for safety and efficacy of IMM01-STEM on muscle performance in seniors with obesity and muscle weakness
Phase: PHASE2 • Sponsor: Immunis, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Smart pill tech targets HIV treatment gaps
Disease control Recruiting nowThis study integrates technology-based adherence measures with alerts for social and behavioral determinants of health (SBDOH) to improve HIV treatment outcomes. It involves 110 adult patients from a Los Angeles County HIV clinic, focusing on those at risk for poor adherence. Par…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Dead bacteria may protect elderly from lung infections
Prevention OngoingPeople living in NH are at higher risk of respiratory infections compared to their counterpart living in the community. Products obtained from dead bacteria ("bacterial lysate") can be used to boost immune system and may reduce the risk of respiratory infections. Very little info…
Phase: PHASE4 • Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Prevention
Last updated Jun 26, 2026 18:38 UTC
-
Could a single zap of radiation tame a stubborn racing heart?
Disease control Recruiting nowThis is a research study that aims to understand if giving a lower dose of treatment all at once is as effective and safe as dividing it into three smaller doses for patients with a heart condition called refractory ventricular tachycardia (VT). These patients have not exhibited …
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Tailored brain zaps show promise for stroke recovery
Symptom relief Recruiting nowThe central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomark…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New diabetes shot could cut injections in half
Disease control CompletedThis is a study to evaluate the impact and efficacy of Efsubaglutide Alfa injection 3mg QoW on the treatment of type 2 diabetes patients with poor glycemic control after dietary and exercise intervention. Primary objective: To evaluate the effect and role of continuous treatmen…
Phase: PHASE2 • Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:54 UTC
-
New drug aims to tame severe eczema in kids and teens
Disease control CompletedThis trial was designed to evaluate the safety of SHR-1819 in children and adolescents with moderate-to-severe atopic dermatitis.
Phase: PHASE1, PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a diabetes drug also mend hearts? new study in kazakhstan investigates
Disease control OngoingThis clinical study aims to improve the diagnosis and treatment of cardiovascular diseases in Kazakhstan by Implementing Metabolic Correction with Glucagon-Like Peptide-1 (GLP-1). These medicines are called incretin-based therapies and include GLP-1 receptor agonists and a newer …
Phase: NA • Sponsor: Nazarbayev University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Nerve zapping: which side works best for migraines?
Symptom relief CompletedThis study is designed to compare the clinical effectiveness of unilateral and bilateral Greater Occipital Nerve Pulsed Radiofrequency (GON-PRF) treatment at the C2 level in patients with migraine. The procedure will be guided by ultrasound and will focus on evaluating how each t…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
3D scan could spot hidden mouth infections in heart patients
Diagnosis Recruiting now1\. Infective Endocarditis (IE) is a rare and serious disease with high morbidity and mortality; 2. Streptoccoci of oral origin are the second more frequent microorganisms responsible for IE; 3. Oral Infectious Foci (OIF) are underdetected using the current recommended clinical e…
Phase: NA • Sponsor: Nantes University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Could a gentle brain zap tame Hard-to-Treat seizures?
Disease control Recruiting nowThe goal of this clinical trial is to to obtain a significant decrease in seizure frequency in patients with refractory focal epilepsy after applying treatment of cathodal tDCS, compared to sham stimulation drug-resistant epileptic patient. The main questions it aims to answer ar…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC